正在加载公司
CVSCVS Health CorpUS$114.5BAJust reported
From The Cigna's results release of 2026年11月5日; its quarterly report has since been filed.
Actual
US$73.68B
+5.6% y/y
+2.8% q/q
Guided
—
No guide given
Actual
US$5.47
-22% y/y
-13% q/q
Guided
—
No guide given
Actual
US$2.4B
-7.1% y/y
-10% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
各项收入占比是对three months ended June 30, 2026的估算，并非来自已提交报告的数字。
Express Scripts pharmacy benefit services
Manages prescription claims and pharmacy networks for client health plans, helps clients choose which drugs their plans cover, and negotiates drug discounts and rebates.
Accredo Specialty Pharmacy
Dispenses medicines for complex or rare conditions and provides patients with support from pharmacists, clinicians and in-home nursing services.
CuraScript SD
Supplies specialty medicines and medical products directly to hospitals, clinics and other health care providers.
Cigna employer health plans
Medical insurance and plan-administration services for employers, with options for employers that pay their employees' medical claims themselves.
International Health coverage
Health and related insurance for multinational employers, people working across borders, and employers and individuals in selected countries.
MD Live and EviCore care services
MD Live provides virtual medical and behavioral health visits; EviCore helps health plans manage coverage and care for certain medical services.
Cigna processes prescription claims and manages pharmacy networks and drug coverage for clients. It also runs home-delivery and specialty pharmacies, supplies specialty medicines to clinics and hospitals, and provides virtual care and medical care-management services. Its insurance business sells health coverage and administers employer health plans, including plans where the employer pays medical claims itself.
基于 The Cigna Group 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
The themes The Cigna is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$301.43-0.6%11月11日 收盘
数据截至2026年9月30日，来自2026年11月5日提交的10-Q
Cigna sells prescription-drug benefits and pharmacy services to employers, health plans and government programs, plus medical insurance to employers and individuals.
Grade A
价格下方的色带显示每个日期的评级，仅依据当时已公开的文件计算。
显示 The Cigna Group 评级历史 32 个季度中的 2 个。 其余 30 个可回溯到 2019年2月。
